The effects of ceftriaxone by intravenous push on adverse drug reactions in the emergency department.

Author: AgunbiadeAbdulkareem, BleifussWill, MoskoffJordan, RizvanolliLum, RoutsoliasJoanne C, SundaresanSharadram

Paper Details 
Original Abstract of the Article :
OBJECTIVE: At our hospital, a shortage of sterile saline bags led to changing ceftriaxone from intravenous infusion to intravenous push. We examined if this change led to an increase in adverse reactions. METHODS: We conducted a retrospective chart analysis on patients 18 and older that were admini...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ajem.2020.03.022

データ提供:米国国立医学図書館(NLM)

Ceftriaxone Administration: Exploring Safety and Efficiency

Drug administration methods are constantly evolving, and healthcare providers are always seeking ways to improve safety and efficiency. This study investigates the safety of administering ceftriaxone, a common antibiotic, by intravenous push (IVP) as opposed to intravenous infusion, a change prompted by a shortage of sterile saline bags.

The researchers conducted a retrospective chart review to assess the rate of adverse reactions associated with IVP ceftriaxone administration in the emergency department. They found that the rate of adverse reactions was lower than previously reported, suggesting that IVP administration may be a safe and viable alternative to intravenous infusion.

Potential Benefits of IVP Administration

The findings of this study could lead to changes in clinical practice, potentially improving efficiency and reducing costs associated with ceftriaxone administration. This is like finding a more efficient way to navigate the desert, allowing the caravan to travel faster and with fewer resources. However, the authors emphasize the need for further research to confirm these findings and explore the implications for patient care.

Dr. Camel's Conclusion

This study is like a camel caravan discovering a new shortcut through the desert. It suggests that IVP administration of ceftriaxone may be a safe and efficient alternative to intravenous infusion, potentially improving patient care and reducing costs. However, further research is needed to confirm these findings and explore the potential impact on clinical practice.

Date :
  1. Date Completed 2021-06-16
  2. Date Revised 2021-06-16
Further Info :

Pubmed ID

32291165

DOI: Digital Object Identifier

10.1016/j.ajem.2020.03.022

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.